Document ID: chunk:federal_register_of_legislation:F2022C00756:schedule:1:p4
Version: federal_register_of_legislation:F2022C00756
Segment Type: schedule
Provision Reference: sch 1 (pt 4/5)
Character Range: 33000–45845

ozone; or
                                                                                                                  (zf) phosgene; or
                                                                                                                  (zg) phosphorus; or
                                                                                                                  (zh) selenium; or
                                                                                                                  (zi) styrene; or
                                                                                                                  (zj) thallium; or
                                                                                                                  (zk) tin; or
                                                                                                                  (zl) toluene; or
                                                                                                                  (zm) toxic halogen derivatives of aliphatic; or
                                                                                                                  (zn) toxic nitro-derivatives of benzene; or
                                                                                                                  (zo) vanadium; or
                                                                                                                  (zp) zinc.
Skin diseases
  39                            Irritant contact dermatitis                                                       Employment for at least 4 weeks (whether consecutive or not) involving work and contact with:
                                                                                                                    (a)     alcohols; or
                                                                                                                    (b)    cutting fluids; or
                                                                                                                    (c)     cleaners; or
                                                                                                                    (d)    degreasers; or
                                                                                                                    (e)     disinfectants; or
                                                                                                                    (f)     liquids (frequent contact); or
                                                                                                                    (g)    liquids (prolonged contact); or
                                                                                                                    (h)    petroleum products; or
                                                                                                                    (i)      soaps; or
                                                                                                                    (j)      solvents.
  40                            Allergic contact dermatitis                                                       Employment for at least 4 weeks (whether consecutive or not) involving work and contact with:
                                                                                                                    (a)     2,5-diaminotoluene sulfate; or
                                                                                                                    (b)    4-phenylenediamine base; or
                                                                                                                    (c)     ammonium persulfate; or
                                                                                                                    (d)    cobalt chloride; or
                                                                                                                    (e)     cocamide diethanolamide; or
                                                                                                                    (f)     coconut diethanolamide; or
                                                                                                                    (g)    colophonium/colophony/rosin; or
                                                                                                                    (h)    diazolidinyl urea; or
                                                                                                                    (i)      epoxy resin; or
                                                                                                                    (j)      formaldehyde; or
                                                                                                                    (k)    fragrance mix I:
                                                                                                                        (i) amylcinnamaldehyde; or
                                                                                                                        (ii) cinnamic alcohol; or
                                                                                                                        (iii) cinnamic aldehyde;
                                                                                                                        (iv) eugenol; or
                                                                                                                        (v) geraniol; or
                                                                                                                        (vi) hydroxycitronellal; or
                                                                                                                        (vii) isoeugenol; or
                                                                                                                        (viii) oakmoss absolute; or
                                                                                                                    (l)      fragrance mix II:
                                                                                                                        (i) citral; or
                                                                                                                        (ii) citronellol; or
                                                                                                                        (iii) coumarin; or
                                                                                                                        (iv) farnesol; or
                                                                                                                        (v) hexyl cinnamic aldehyde; or
                                                                                                                        (vi) hydroxyisohexyl 3-cyclohexene carboxaldehyde; or
                                                                                                                    (m)  glyceryl monothioglycolate; or
                                                                                                                    (n)    hydroxyethyl methacrylate; or
                                                                                                                    (o)    mercaptobenzothiazole; or
                                                                                                                    (p)    methyl chloroisothiazolinone; or
                                                                                                                    (q)    mixture of methylchloroisothiazolinone and methylisothiazolinone; or
                                                                                                                    (r)     nickel sulfate; or
                                                                                                                    (s)     potassium dichromate; or
                                                                                                                    (t)      quaternium 15; or
                                                                                                                    (u)    thiuram mix:
                                                                                                                        (i) tetramethylthiuramdisulfide; or
                                                                                                                        (ii) tetramethylthiuram monosulfide; or
                                                                                                                        (iii) tetraethylthiuram disulfide.

  41                      Occupational vitiligo                                                                           Employment for at least 4 weeks (whether consecutive or not) involving work with:
                                                                                                                            (a)     hydroquinone; or
                                                                                                                            (b)    monobenzyl ether of hydroquinone; or
                                                                                                                            (c)     monobutyl ether of hydroquinone; or
                                                                                                                            (d)    para-amylphenol; or
                                                                                                                            (e)     para-tertiary-butylcatechol; or
                                                                                                                            (f)     para-tertiary-butylphenol.
Musculoskeletal diseases
  42                      Raynaud's disease                                                                               Employment for at least 12 weeks (whether consecutive or not) involving work with:
                                                                                                                            (a)     powered equipment that produces vibration; or
                                                                                                                            (b)    powered tools that produce vibration.
  43                      Bursitis at the elbow or knee                                                                   Employment for at least 6 months (whether consecutive or not) involving a work activity that:
                                                                                                                            (a)     for bursitis at the elbow:
                                                                                                                                (i) involves prolonged external friction at or about the elbow; or
                                                                                                                                (ii) involves prolonged external pressure at or about the elbow; or
                                                                                                                                (iii) involves recurrent external friction at or about the elbow; or
                                                                                                                                (iv) involves recurrent external pressure at or about the elbow; or
                                                                                                                            (b)    for bursitis at the knee:
                                                                                                                                (i) involves prolonged external friction at or about the knee; or
                                                                                                                                (ii) involves prolonged external pressure at or about the knee; or
                                                                                                                                (iii) involves recurrent external friction at or about the knee; or
                                                                                                                                (iv) involves recurrent external friction at or about the knee.
Acute diseases